$1.93
-0.06-3.02%
最終更新: Oct 19, 10:32 AM
$2.10
0.115.53%
Benzinga
Benzinga
Benzinga
月曜日, 10 19
Benzinga
© 2026 Benzinga | All Rights Reserved
Xenetic Biosciences (XBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | $-0.52 | $-0.51 |
| Actual | $-0.41 | $-0.20 | $-0.22 | $-0.33 |
| Surprise | — | — | +57.7% | +35.3% |
| Revenue | ||||
| Estimate | — | — | $525000 | $525000 |
| Actual | $660601 | $806923 | $766296 | $1.0M |
| Surprise | — | — | +46.0% | +95.6% |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 13, 2026 | $-0.22 | $-0.52 | 57.7 % |
| Q3 | Nov 13, 2025 | $-0.33 | $-0.51 | 35.3 % |
| Q2 | Aug 13, 2025 | $-0.45 | $-0.65 | 29.7 % |
| Q1 | May 13, 2025 | $-0.59 | $-0.72 | 18.1 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 13, 2026 | $766.30K | $525.00K | 46.0 % |
| Q3 | Nov 13, 2025 | $1.03M | $525.00K | 95.6 % |
| Q2 | Aug 13, 2025 | $589.90K | $545.20K | 8.20 % |
| Q1 | May 13, 2025 | $593.26K | $516.00K | 15.0 % |